Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRT
2676
DELISTED
HireRight Holdings Corporation
HRT
| $1.48M | ﹤0.01% |
103,899
+5,743
| +6% | +$77K |
|
2677
Gossamer Bio
GOSS
$84.9M
| $1.48M | ﹤0.01% |
1,252,764
+32,935
| +3% | +$36.3K |
|
2678
ProFrac Holding
ACDC
$744M
| $1.48M | ﹤0.01% |
176,623
+3,055
| +2% | +$23.5K |
|
2679
Humacyte
HUMA
$186M
| $1.47M | ﹤0.01% |
473,767
-17,490
| -4% | -$58.8K |
|
|
LLAP
2680
DELISTED
Terran Orbital Corporation
LLAP
| $1.47M | ﹤0.01% |
1,119,063
-84,670
| -7% | -$85.6K |
|
2681
908 Devices
MASS
$345M
| $1.46M | ﹤0.01% |
193,884
+13,223
| +7% | +$98K |
|
|
LBPH
2682
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.46M | ﹤0.01% |
67,641
+24,708
| +58% | +$539K |
|
|
STKL
2683
DELISTED
SunOpta
STKL
| $1.46M | ﹤0.01% |
212,274
-4,338
| -2% | -$26.8K |
|
2684
Riley Exploration Permian
REPX
$740M
| $1.46M | ﹤0.01% |
44,116
+470
| +1% | +$11.8K |
|
2685
Altimmune
ALT
$583M
| $1.45M | ﹤0.01% |
142,705
| – | – |
|
2686
Oric Pharmaceuticals
ORIC
$1.1B
| $1.44M | ﹤0.01% |
104,544
-2,057
| -2% | -$24.4K |
|
2687
Astronics
ATRO
$3.51B
| $1.43M | ﹤0.01% |
89,894
+3,126
| +4% | +$46.5K |
|
|
BBUC
2688
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.42B
| $1.42M | ﹤0.01% |
58,975
-550
| -0.9% | -$12.7K |
|
2689
BRC Inc
BRCC
$123M
| $1.42M | ﹤0.01% |
331,374
+6,985
| +2% | +$29K |
|
2690
Rimini Street
RMNI
$447M
| $1.41M | ﹤0.01% |
434,003
+171,872
| +66% | +$549K |
|
|
AGEN
2691
Agenus
AGEN
$326M
| $1.41M | ﹤0.01% |
121,762
-14,881
| -11% | -$197K |
|
2692
Inspired Entertainment
INSE
$183M
| $1.41M | ﹤0.01% |
142,827
| – | – |
|
|
CATC
2693
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.41M | ﹤0.01% |
20,652
-455
| -2% | -$30.2K |
|
2694
Business First Bancshares
BFST
$1.04B
| $1.4M | ﹤0.01% |
62,984
-2,677
| -4% | -$59.9K |
|
2695
i3 Verticals
IIIV
$418M
| $1.4M | ﹤0.01% |
61,275
-1,301
| -2% | -$27K |
|
2696
Ivanhoe Electric
IE
$1.54B
| $1.4M | ﹤0.01% |
142,693
-3,278
| -2% | -$28.2K |
|
|
MRNS
2697
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.4M | ﹤0.01% |
154,667
+5,241
| +4% | +$50.9K |
|
2698
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$681M
| $1.4M | ﹤0.01% |
24,540
-970
| -4% | -$51.9K |
|
2699
ArriVent BioPharma
AVBP
$1.38B
| $1.39M | ﹤0.01% |
+77,760
| New | +$1.57M |
|
2700
Kodiak Sciences
KOD
$2.49B
| $1.38M | ﹤0.01% |
263,276
+22,280
| +9% | +$109K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.